Tomoki Motegi

Tomoki Motegi

BioNTech - / Germany
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 5470870
person_outline Tomoki Motegi's MOST POPULAR ARTICLES
1-) Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogsS Maeda, K Sakai, K Kaji, A Iio, M Nakazawa, T Motegi, T Yonezawa, ...Scientific Reports 12 (1), 4, 2022312022
2-) Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancerS Maeda, T Motegi, A Iio, K Kaji, Y Goto-Koshino, S Eto, N Ikeda, ...Journal for immunotherapy of cancer 10 (2), 2022282022
3-) Evaluation of anticancer effects and enhanced doxorubicin cytotoxicity of xanthine derivatives using canine hemangiosarcoma cell linesT Motegi, M Katayama, Y Uzuka, Y OkamuraResearch in veterinary science 95 (2), 600-605, 2013272013
4-) Identification of rare coding variants in TYK2 protective for rheumatoid arthritis in the Japanese population and their effects on cytokine signallingT Motegi, Y Kochi, K Matsuda, M Kubo, K Yamamoto, Y MomozawaAnnals of the rheumatic diseases 78 (8), 1062-1069, 2019202019
5-) Efficacy and safety of 0.0584% hydrocortisone aceponate topical spray and systemic oclacitinib combination therapy in dogs with atopic dermatitis: a randomized, double‐blinded …J Takahashi, S Kanda, I Imanishi, T Hisano, T Fukamachi, N Taguchi, ...Veterinary Dermatology 32 (2), 119-e25, 2021172021